Priority Date: 19.05.11 (EP 20110166815)

BOMBESIN RECEPTOR TARGETING PEPTIDE INCORPORATING A 1, 2, 3-TRIAZOLE GROUP IN THE BACKBONE FOR PREPARING IN VIVO DIAGNOSTIC AND THERAPEUTIC AGENTS

  • Application ID: EP12724303
  • Status: APPLICATION DEEMED TO BE WITHDRAWN

Attorney

operating since 2012
Headquarter in Basel
active in Legal Services

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY) Latscha Schöllhorn Partner AG is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 185 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 19.05.2011 - Priority Date (EP 20110166815)
  • 22.11.2012 - Publication A1 (WO2012156511)
  • 26.03.2014 - Publication A1 (EP2710027)